ActivityTopicFaculty ChairLaunch DateCreditExpiration Date
Allergy/ Immunology
icon_478412.jpgCase Challenges in Chronic Urticaria: Optimizing Patient Assessment & ManagementAllergy/ ImmunologyAllen P. Kaplan, MD20-Nov-151.25 AMA
20-Nov-16478412
icon_502661.jpgChallenging Cases in AngioedemaAllergy/ ImmunologyMarc Riedl, MD, MS29-Mar-161 AMA
29-Mar-17502661
icon_513252.jpgClinical Convergence℠: Patient and Provider Perspectives on Care for Chronic Urticaria (CU)Allergy/ ImmunologyMichael E. Manning, MD26-May-161.25 AMA
26-May-17513252
icon_490101.jpgClinical Convergence℠: Patient and Provider Perspectives on Care for Hereditary Angioedema: Follow-up VisitsAllergy/ ImmunologyMarc Riedl, MD, MS24-Mar-161.25 AMA
24-May-17490101
icon_515272.jpgClinical Convergence℠ - Patient and Provider Perspectives on Care for Hereditary Angioedema: Initial VisitsAllergy/ ImmunologyMarc Riedl, MD, MS24-Mar-161.25 AMA
24-May-17515272
Cardiology
icon_492831.jpgAF Spotlight: Using NOACs Safely: Focus on Bleeding IssuesCardiologyChristrian T. Ruff, MD, MPH16-Feb-161 AMA
16-Feb-17492831This activity is part 2 of a 2-part series on using Non-VKA anticoagulants (NOACs) in patients with atrial fibrillation
icon_483766.jpgAF Spotlight: Using NOACs Safely: Overview, Dosing, Transitioning, and Using a Patient-centered ApproachCardiologyA. John Camm, MD05-Jan-161.5 AMA
05-Jan-17483766The best information available on managing stroke prevention with novel oral anticoagulants for patients with atrial fibrillation.
icon_.pngA Heart Failure Self AssessmentCardiologyJaved Butler, MD MPH FACC FAHA22-Sep-151 AMA
22-Sep-16436052Self assessment of CHF knowledge
icon_503376.jpgCase Challenges in Lipid Management: PCSK9 Inhibitors in PracticeCardiologyChristopher Paul Cannon, MD07-Apr-161.5 AMA
07-Apr-17503376Case studies highlighting the use of PCSK9 inhibitors in clinical practice.
icon_533132.jpgEvolving Guidelines and Targets: When and How to Use the PCSK9 InhibitorsCardiologyChristopher Paul Cannon, MD13-Sep-161.5 AMA
13-Sep-17533132
icon_435924.jpgHeart Failure Management: Current and Future ChallengesCardiologyBarry Greenberg, MD01-Oct-151 AMA
01-Oct-16435924ent and emerging management approaches for heart failure.An interactive digital enduring activity focused on curr
icon_494049.jpgHeart Failure - Optimizing Therapy with Recently Approved Novel AgentsCardiologyGregg Fonarow, MD, FACC, FAHA29-Dec-151.5 AMA
29-Dec-16494049An interactive digital enduring activity focused on current and emerging management approaches for heart failure.
icon_535862.jpgIndividualizing Heart Failure TreatmentCardiologyBarbara A. Hutchinson, MD, PhD, FACC19-Oct-161 AMA
1 AANP
18-Oct-17535862
icon_473131.jpgIndividualizing Therapy in Patients with Heart FailureCardiologyMariell L. Jessup, MD24-Nov-151 AMA
24-Nov-16473131An interactive digital enduring activity focused on current and emerging management approaches for heart failure.
icon_524503.jpgLipid-lowering Therapies for Familial HypercholesterolemiaCardiologyP. Barton Duell, MD, FNLA, FAHA04-Aug-160.75 AMA
04-Aug-17524503
icon_520931.jpgLipid-lowering Therapy for ASCVD: Guidelines and AgentsCardiologyTy J. Gluckman, MD, FACC, FAHA04-Aug-160.75 AMA
04-Aug-17520931
icon_515046.jpgPart 1: LDL-C Reduction in the Patient with Diabetes: How Low Should We Go and How Should We Get There?CardiologyYehuda Handelsman, MD, FACP, FACE, FNLA21-Jul-161 AMA
21-Jul-17515046The most recent evidence on PCSK9 inhibition, relationship of diabetes and dyslipidemia, and current lipid-lowering guidelines.
icon_521263.jpgPart 2: LDL-C Reduction in the Patient with Diabetes: How Low Should We Go and How Should We Get There?CardiologyYehuda Hendelsman, MD16-Aug-160.75 AMA
21-Jul-17521263This course covers the most recent evidence on PCSK9 inhibition, relationship of diabetes and dyslipidemia, and current guidelines.
icon_479964.jpgPCSK9 Inhibitors: Basics and Use in DyslipidemiaCardiologyChristopher Paul Cannon, MD16-Dec-151.5 AMA
16-Dec-16479964A review of key clinical trial data for PCSK9 inhibitors and discussion of their potential role in clinical practice.
icon_539352.jpgRecognizing and Managing Heart Failure in Primary CareCardiologyAnekwe Onwuanyi, MD, FACC, FAHA,FACP, FHFSA20-Oct-161 AMA
1 AANP
19-Oct-17539352
Dermatology
icon_438876.jpgCase Challenges in Psoriasis and Psoriatic ArthritisDermatologyPhilip J. Mease, MD12-Jun-150.75 AMA
11-Jun-16438876A cased-based activity focusing on a variety of dx and tx issues
icon_437924.jpgClinical Review - Improving Outcomes in Patients with Psoriasis and Psoriatic ArthritisDermatologyPhilip J. Mease, MD12-Jun-150.75 AMA
11-Jun-16437924Improving Outcomes in Patients with Psoriasis and Psoriatic Arthritis
icon_431916.jpgImproving Outcomes in Patients with Psoriasis and Psoriatic Arthritis - A Self-assessment ProgramDermatologyPhilip J. Mease, MD07-May-150.75 AMA
12-Jun-16431916Optimal management of psoriasis and PsA: Achieve an accurate diagnosis and balance the benefits and risks of treatment
Diabetology
icon_468060.jpgTargeted Combined Approaches for the Treatment of Type 2 Diabetes: The Role of the KidneyDiabetologyJennifer B. Green, MD27-Oct-151 AMA
27-Oct-16468060This program will focus on the unmet need to control hyperglycemia in patients with T2DM and review novel treatment strategies.
Gastroenterology
icon_457126.jpgA Performance Measures-Based Patient-Centric Approach to IBDGastroenterologyAdam S. Cheifetz, MD13-Oct-151 AMA
13-Oct-16457126
icon_457197.jpgDisease Monitoring and Treatment for IBDGastroenterologyGil Y. Melmed, MD, MS30-Nov-151 AMA
30-Nov-16457197
icon_386023.jpgIBD in Clinical Practice: Diagnosis and Medical TreatmentGastroenterologyMiguel Regueiro, MD02-Dec-141 AMA
03-Apr-17386023Case-based activity: See how well you can manage inflammatory bowel disease according to symptoms, duration, and severity of disease.
icon_386211.jpgIBD in Clinical Practice: Long-term Disease Management and SurgeryGastroenterologyMiguel Regueiro, MD02-Dec-140.5 AMA
03-Apr-17386211Choose acute and long-term medical therapy for inflammatory bowel disease and decide when surgery is indicated.
icon_458718.jpgMaximizing Therapeutic Safety and Efficacy in IBD: A Treat-to-Target ApproachGastroenterologyMiguel Regueiro, MD, AGAF, FACG, FACP28-Jul-151.5 AMA
28-Jul-16458718
icon_480397.jpgStrategies for Safe and Efficacious Use of New and Emerging Therapies in HCV (Enduring)GastroenterologyIra Jacobson, MD03-Nov-151 AMA
31-Jul-17480397
icon_501493.jpgStrategies for Safe and Efficacious Use of New and Emerging Therapies in HCV: Interact with HCV Experts on Patient CasesGastroenterologyAndrew J. Muir, MD, MHS, FACP15-Mar-161 AMA
31-Jul-17501493
icon_496466.jpgTherapeutic Options for Achieving Realistic Management Goals with Your IBS PatientsGastroenterologyH. Christian Weber, MD23-Feb-161 AMA
1 ANCC
23-Feb-17496466
Hematology-Oncology
icon_424647.jpgAdvances in NSCLC From Clinical Research to Clinical PracticeHematology-OncologyDaniel Morgensztern, MD07-May-151.25 AMA
07-Jun-16424647
icon_518856.jpgA Patient-Centric, Performance Measures-Based Approach to NSCLCHematology-OncologyDaniel Morgensztern, MD23-Aug-161 AMA
23-Aug-17518856
icon_490456.jpgClinical Convergence℠: Patient and Provider Perspectives in NSCLC: Follow-up VisitsHematology-OncologyJared Weiss, MD31-Mar-161 AMA
28-Apr-17490456
icon_490275.jpgClinical Convergence℠: Patient and Provider Perspectives in NSCLC: Initial VisitsHematology-OncologyJared Weiss, MD31-Mar-161.5 AMA
28-Apr-17490275
icon_477861.jpgManaging the Patient with Metastatic Melanoma: A Comprehensive, Evidence-Based ApproachHematology-OncologyKeith T. Flaherty, MD08-Jan-161 AMA
08-Jan-17477861
icon_425323.jpgMetastatic Colorectal Cancer: Improving Care Across the Disease ContinuumHematology-OncologyJohn L. Marshall, MD21-May-151 AMA
21-May-16425323
icon_511109.pngNuances in Treating NSCLCHematology-OncologyRoy S. Herbst, MD, PhD21-Jul-160.5 AMA
08-Feb-17511109
icon_571517.pngNuances in Treating NSCLCHematology-OncologyRoy S. Herbst, MD, PhD21-Jul-160.5 AMA
21-Jul-17571517
axis33455.jpgOptimizing Management of Patients with Chronic Myelogenous Leukemia: Therapeutic Strategies Making A DifferenceHematology-OncologyJerald P. Radich, MDFred Hutchinson Cancer Research Center01-Aug-141 AMA
30-Sep-15384321
icon_492447.jpgOptimizing Patient Care in NSCLC: A Targeted Patient-Centered ApproachHematology-OncologyJared Weiss, MD02-Feb-161 AMA
31-Mar-17492447
icon_524023.jpgPlaying The Offense In Advanced Basal Cell Carcinoma: A Team Approach to Treatment And ManagementHematology-OncologyClifford Perlis, MD12-Jul-161 AMA
12-Jul-17524023
RealCME_Icon_43x43.jpgVirtual Study Groups: Optimizing Management of Patients with Chronic Myelogenous LeukemiaHematology-OncologyJerald P. Radich, MD22-Sep-146 AMA
30-Sep-15394761
Infectious Diseases
icon_505928.pngCase 1 - Initiating ARV TherapyInfectious DiseasesPaul E. Sax, MD31-Mar-161 AMA
30-Jun-17505928
icon_506320.jpgCase 2 - Managing HIV Therapy in Patients with ComorbiditiesInfectious DiseasesPaul E. Sax, MD31-Mar-160.75 AMA
30-Jun-17506320
icon_506769.jpgCase 3 - HIV Treatment Options in the Setting of Drug ResistanceInfectious DiseasesPaul E. Sax, MD31-Mar-160.75 AMA
30-Jun-17506769
icon_397507.jpgNew Insights into Managing HIV-1: Guideline Recommendations, Individualized Treatment, and Management of ComorbiditiesInfectious DiseasesRaphael J. Landovitz, MD, MSc14-Oct-141 AMA
13-Oct-15397507
icon_466517.pngOpportunities in HIV/HCV Coinfection with Pharmacoenhanced PIsInfectious DiseasesAdriana Andrade, MD, MPH, FACP16-Sep-150.5 AMA
0.5 ACPE
15-Sep-17466517
icon_458493.pngPharmacoenhanced PIs -- New Opportunities for the Patient with HIV InfectionInfectious DiseasesAdriana Andrade, MD, MPH, FACP30-Jul-150.5 AMA
0.5 ACPE
29-Jul-17458493
Neurology
icon_476014.jpgOptimizing Differential Diagnosis and Treatment Strategies for Headaches and MigrainesNeurologyStephen D. Silberstein, MD29-Oct-151 AMA
29-Oct-16476014This activity is designed to help HCPs in optimizing their management strategies for patients with headaches and migraines.
icon_493149.jpgSelecting Evidence-Based Pharmacologic Therapy and Designing Multimodal Treatment Plans for Migraine and HeadacheNeurologyStephen D. Silberstein, MD10-Dec-151 AMA
10-Dec-16493149
icon_401446.jpgUpdating and Advancing the Management of DMD Therapy in Multiple SclerosisNeurologySuhayl Dhib-Jalbut, MD06-Nov-141 AMA
06-Nov-15401446
Psychiatry
icon_495281.jpgImproving Treatment Outcomes through Appropriate Pharmacotherapeutic Selection and Patient Assessment for Readiness to ChangePsychiatryRoger D. Weiss, MD, Chair17-Dec-151 AMA
1 APA
17-Dec-16495281This activity will describe and illustrate patient and disease-related considerations in medication-assisted treatment of OUD.
icon_481659.jpgOptimizing Treatment Selection for Opioid Use Disorder: Tailoring Mat Strategies to Improve Patient OutcomesPsychiatryRoger D. Weiss, MD05-Nov-151 AMA
05-Nov-16481659This activity will describe and illustrate patient and disease-related considerations in medication-assisted treatment of OUD.
Pulmonary Disease
icon_527340.jpgA Case-based Approach to Diagnosing Pulmonary Arterial Hypertension in Primary CarePulmonary DiseaseFranck Rahaghi, MD, MHS, FCCP01-Sep-160.5 AMA
0.5 AAFP
0.5 AANP
31-Aug-17527340
icon_487411.jpgDiagnosing and Managing Pulmonary Arterial Hypertension in Primary CarePulmonary DiseaseFranck Rahaghi, MD, MHS, FCCP01-Jan-161 AMA
1 AAFP
1 AANP
31-Dec-16487411
Rheumatology
icon_501302.jpgAchieving Optimal Outcomes for Patients with Rheumatoid Arthritis and Comorbid Conditions: A Team ApproachRheumatologyTuhina Neogi, MD, PhD17-May-161 AMA
1 ANCC
17-May-17501302
icon_451448.pngApplying Evidence to Real-world RA Management: A Case-based ApproachRheumatologyMarc D. Cohen, MD28-May-151 AMA
28-May-16451448This case-based activity will explore therapeutic options for the treatment of rheumatoid arthritis in a patient intolerant to methotrexate.
icon_469426.jpgAvoiding Missed Opportunities in PsA: Early Recognition, Optimal Therapy, and Coordination of CareRheumatologyM. Elaine Husni, MD, MPH15-Sep-151 AMA
15-Sep-16469426
icon_427531.jpgCase Challenges in the Evidence-based Management of Rheumatoid ArthritisRheumatologyMichael York, MD18-Feb-151 AMA
1 ANCC
17-Feb-16427531
icon_494717.jpgClinical Updates on Rheumatoid ArthritisRheumatologyBarbara L. Goldstein, MD, MMSc23-Dec-151 AMA
22-Dec-16494717How will you manage Kate’s rheumatoid arthritis over the next 5 years? Find out about treatment updates & disease activity measures.
icon_565921.jpgEarly Recognition, Accurate Diagnosis, and Appropriate Treatment Selection in Psoriatic ArthritisRheumatologyJose U. Scher, MD09-Feb-170.5 AMA
14-Feb-17565921
icon_420881.jpgEvidence-based Rheumatoid Arthritis Treatment: A Self-assessment ProgramRheumatologyMichael York, MD13-Jan-151 AMA
1 ANCC
12-Jan-16420881
icon_424260.jpgInitial Diagnosis and Management of Rheumatoid Arthritis -- An Evidence-based ApproachRheumatologyMichael York, MD18-Feb-151 AMA
1 ANCC
17-Feb-16424260
icon_565781.jpgPsoriatic Arthritis: Recognition, Diagnosis, and ManagementRheumatologyJose U. Scher, MD09-Feb-170.5 AMA
14-Feb-17565781
icon_405408.gifRheumatoid Arthritis: Current Studies, Therapeutic Options and Mechanisms of ActionRheumatologyGregg J. Silverman, MD17-Mar-151 AMA
17-Mar-16405408This course examines the mechanisms of action of rheumatoid arthritis, the DMARDs used as therapy, and current practice guidelines.
icon_503094.pngWhen It's Not Mechanical Back Pain: What the PCP Needs to KnowRheumatologyLianne S. Gensler, MD28-Apr-160.5 AMA
27-Apr-17503094
Sleep Disorders
icon_474094.jpgSweet Dreams - Improving Outcomes for Patients With InsomniaSleep DisordersLarry Culpepper, MD, MPH29-Sep-151 AMA
1 ANCC
29-Sep-16474094Insomnia - a health issue in your patients. Stay up-to-date. Earn CME/CE with Real Patient Case Scenarios and Expert Insights.